Elanco/$ELAN
13:30
21:10
04:45
12:25
20:00
1D1W1MYTD1Y5YMAX
About Elanco
Elanco Animal Health is an animal health company that is engaged in developing, manufacturing, and marketing pharma products for companion and food animals. It spun off from Eli Lilly in 2018 and acquired Janssen Animal Health in 2011, Novartis Animal Health in 2014, Boehringer Ingelheim Vetmedica in 2017, and Bayer Animal Health in 2020. The company's operations are conducted globally, and it sells its products in over 90 countries. It offers a range of food animal products used in cattle, sheep, goats, and swine production.
Ticker
$ELAN
Sector
Trading on
NYSE
Industry
Pharmaceuticals
Headquarters
Employees
9,225
ISIN
US28414H1032
Website
Elanco Metrics
BasicAdvanced
$6.7B
17.92
$0.75
1.50
-
Price and volume
Market cap
$6.7B
Beta
1.5
52-week high
$18.80
52-week low
$8.02
Average daily volume
6.5M
Financial strength
Current ratio
2.711
Quick ratio
1.219
Long term debt to equity
68.487
Total debt to equity
69.18
Interest coverage (TTM)
1.17%
Management effectiveness
Return on assets (TTM)
1.14%
Return on equity (TTM)
6.01%
Valuation
Price to earnings (TTM)
17.92
Price to revenue (TTM)
1.5
Price to book
1.05
Price to tangible book (TTM)
-3.73
Price to free cash flow (TTM)
19.942
Growth
Revenue change (TTM)
1.42%
Earnings per share change (TTM)
-128.31%
3-year revenue growth (CAGR)
-2.31%
3-year earnings per share growth (CAGR)
-0.84%
What the Analysts think about Elanco
Analyst ratings (Buy, Hold, Sell) for Elanco stock.
Elanco Financial Performance
Revenues and expenses
Elanco Earnings Performance
Company profitability
Elanco News
AllArticlesVideos
Animal Health Elanco Chirps A Solid Quarter Tempered By Soft Q2 EPS Guide
Benzinga·4 weeks ago
Elanco Animal Health Sells Xdemvy Royalties To Blackstone in $295 Million Deal
Benzinga·1 month ago
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Elanco Animal Health Incorporated (ELAN) And Encourages Shareholders to Reach Out
Accesswire·1 month ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Elanco stock?
Elanco (ELAN) has a market cap of $6.7B as of June 06, 2025.
What is the P/E ratio for Elanco stock?
The price to earnings (P/E) ratio for Elanco (ELAN) stock is 17.92 as of June 06, 2025.
Does Elanco stock pay dividends?
No, Elanco (ELAN) stock does not pay dividends to its shareholders as of June 06, 2025.
When is the next Elanco dividend payment date?
Elanco (ELAN) stock does not pay dividends to its shareholders.
What is the beta indicator for Elanco?
Elanco (ELAN) has a beta rating of 1.5. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.